Moreover, the numbers of tumor-infiltrating CD3 + T cells and CD8 + T cells but not CD4 + T cells and CD11B + myloid cells, were also significantly elevated in mice administered with a combination of capmatinib and anti-PD-L1 antibody (Fig. 7F-G, Figures S5C-5D). The gene discussed is CD4; the disease is neoplasm.